Loading…
Relationship and significance between anti-β2-glycoprotein Ⅰ antibodies and platelet activation state in patients with ulcerative colitis
AIM: To study the relationship between anti-β2- glycoprotein Ⅰ (aβ2GPⅠ) antibodies and platelet activation state in patients with ulcerative colitis (UC) and its significance. METHODS: Peripheral blood samples were collected from 56 UC patients (34 males and 22 females, aged 43.5 years, range 21-66...
Saved in:
Published in: | World journal of gastroenterology : WJG 2008-02, Vol.14 (5), p.771-775 |
---|---|
Main Author: | |
Format: | Article |
Language: | English |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | AIM: To study the relationship between anti-β2- glycoprotein Ⅰ (aβ2GPⅠ) antibodies and platelet activation state in patients with ulcerative colitis (UC) and its significance.
METHODS: Peripheral blood samples were collected from 56 UC patients (34 males and 22 females, aged 43.5 years, range 21-66 years), including 36 at active stage and 20 at remission stage, and 25 sex-and age-matched controls. The level of aβ2GP Ⅰ was measured by ELISA. The platelet activation markers, platelet activation complex- Ⅰ (PAC- Ⅰ ) and P-selectin (CD62P) were detected by flow cytometry.
RESULTS: The A value for IgG aβ2GP Ⅰ in the active UC group was 0.61 ± 0.13, significantly higher than that in the remittent UC and control groups (0.50 ± 0.13 and 0.22 ± 0.14, P 〈 0.01). There was a significant difference between the two groups (P 〈 0.01). The A value for IgM aβ2GP Ⅰ in the active and remittent UC groups was 0.43 ± 0.13 and 0.38 ± 0.12, significantly higher than that in the control group (0.20 ± 0.12, P 〈 0.01). However, there was no significant difference between the two groups (P 〉 0.05). The PAC- Ⅰ positive rate for the active and remittent UC groups was 30.6% ± 7.6% and 19.6% ± 7.8% respectively, significantly higher than that for the control group (6.3% ± 1.7%,P 〈 0.01). There was a significant difference between the two groups (P 〈 0.01). The CD62P positive rate for the active and remittent UC groups was 45.0% ± 8.8% and 31.9% ± 7.8% respectively, significantly higher than that for the control group (9.2% ± 2.7%, P 〈 0.01). There was a significant difference between the two groups (P 〈 0.01). In the active UC group, the more severe the state of illness was, the higher the A value for IgG aβ2GP Ⅰ was, and the positive rate for PAC-Ⅰ and CD62P was positively correlated with the state of illness (Faβ2GP Ⅰ = 3.679, P 〈 0.05; FPAC-Ⅰ (%) = 5.346, P 〈 0.01; and FCD62P (%) = 5. 418, P 〈 0.01). Meanwhile, in the same state of illness, the A value for IgG aβ2GP Ⅰ was positively correlated to the positive rates for PAC-Ⅰ and CD62P.
CONCLUSION: aβ2GP Ⅰ level, platelet activation state and their relationship of them are closely correlated with the pathogenesis and development of UC. |
---|---|
ISSN: | 1007-9327 2219-2840 |
DOI: | 10.3748/wjg.14.771 |